Coya Therapeutics, Inc. (COYA) stock
COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3023% above fair value
$3.13−0.14 (-4.28%)
Close on Nov 13, 2026Market cap $73.42MP/E –Yield –
Coya Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Coya Therapeutics's enterprise value was $32.12M on Nov 11, 2026, against $80.86M a year earlier. Over the last 4 years it ranged from $4.36M to $110.27M, with a median of $60.64M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $32.12M | -53.4% |
| 2025 | Dec 31, 2025 | $68.98M | +22.8% |
| 2024 | Dec 31, 2024 | $56.16M | -10.6% |
| 2023 | Dec 29, 2023 | $62.83M | +692.1% |
| 2022 | Dec 30, 2022 | $7.93M | – |
See a number that looks wrong?